{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:28:22Z","timestamp":1777962502343,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"he Planned Science and Technology Project of Guangdong Province","award":["201707010087"],"award-info":[{"award-number":["201707010087"]}]},{"name":"he Planned Science and Technology Project of Guangdong Province","award":["2016A020215085"],"award-info":[{"award-number":["2016A020215085"]}]},{"name":"the 308 Clinical Research Funding of Sun Yat-Sen University Cancer Center","award":["No 308-2015-011"],"award-info":[{"award-number":["No 308-2015-011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>The study aims to analyze the clinical characteristics of head and neck mucosal melanoma (MMHN) and the effects of multiple treatment modalities on distant metastasis, recurrence and survival rates to provide a reference for the individualized treatment of MMHN.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively reviewed 262 patients with stage III\u2013IVb MMHN treated from March 1986 to November 2018 at our cancer center.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The median follow-up time was 34.0\u00a0months (range 1\u2013262\u00a0months). The 5-year overall survival (OS), distant metastasis-free survival (DMFS) and disease-free survival (DFS) probabilities were 37.7%, 30.2%, and 20.3%, respectively. The 5-year OS rates for patients with stage III, stage IVA, and stage IVB MMHN were 67.0%, 24.1% and 8.3%, respectively (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). A total of 246 (93.9%) patients received surgery, 149 (56.9%) patients received chemotherapy, and 69 (26.3%) patients received immunologic\/targeted therapy. A total of 106 (40.5%) patients were treated with radiotherapy: 9 were treated with preoperative radiotherapy, 93 were treated with postoperative radiotherapy, and 4 were treated with radiotherapy alone. In the multivariate Cox regression analysis, primary tumor site, T stage, and immunologic\/targeted therapy were independent factors for OS (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Irradiation technique, T stage, and N stage were independent prognostic factors for DMFS (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). T stage, N stage, and surgery were independent prognostic factors for DFS (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Distant metastasis was observed in 107 of 262 patients (40.8%), followed by local [74 (28.2%)] and regional [52 (19.8%)] recurrence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The main reason for treatment failure in MMHN is distant metastasis. Immunologic\/targeted therapy and surgery are recommended to improve the survival of MMHN. The American Joint Committee on Cancer (AJCC) 8th edition staging system for MMHN does stage this disease effectively.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-021-01860-z","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T08:03:06Z","timestamp":1627459386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical outcomes and patterns of failure of head and neck mucosal melanoma treated with multiple treatment modalities"],"prefix":"10.1186","volume":"16","author":[{"given":"Qing-Qing","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Zhen","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Lu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Yi","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ni","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Yao","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0549-3786","authenticated-orcid":false,"given":"Li-Xia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,28]]},"reference":[{"key":"1860_CR1","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","volume":"83","author":"AE Chang","year":"1998","unstructured":"Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664\u201378.","journal-title":"Cancer"},{"key":"1860_CR2","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1373::AID-CNCR3>3.0.CO;2-G","volume":"80","author":"S Manolidis","year":"1997","unstructured":"Manolidis S, Donald PJ. Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients. Cancer. 1997;80:1373\u201386.","journal-title":"Cancer"},{"key":"1860_CR3","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/annonc\/mdw694","volume":"28","author":"B Lian","year":"2017","unstructured":"Lian B, Cui CL, Zhou L, Song X, Zhang XS, Wu D, et al. The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients. Ann Oncol. 2017;28:868\u201373.","journal-title":"Ann Oncol"},{"key":"1860_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-2407-11-85","volume":"11","author":"Z Chi","year":"2011","unstructured":"Chi Z, Li S, Sheng X, Si L, Cui C, Han M, et al. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases. BMC Cancer. 2011;11:85.","journal-title":"BMC Cancer"},{"key":"1860_CR5","first-page":"JCO2000902","volume":"25","author":"X Yan","year":"2021","unstructured":"Yan X, Sheng X, Chi Z, Si L, Cui C, Kong Y, et al. Randomized phase II study of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously unt. J Clin Oncol. 2021;25:JCO2000902.","journal-title":"J Clin Oncol"},{"key":"1860_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.oraloncology.2017.09.020","volume":"74","author":"S Sun","year":"2017","unstructured":"Sun S, Huang X, Gao L, Zhang Y, Luo J, Zhang S, et al. Long-term treatment outcomes and prognosis of mucosal melanoma of the head and neck: 161 cases from a single institution. Oral Oncol. 2017;74:115\u201322.","journal-title":"Oral Oncol"},{"key":"1860_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.oraloncology.2017.08.002","volume":"73","author":"MQ Schmidt","year":"2017","unstructured":"Schmidt MQ, David J, Yoshida EJ, Scher K, Mita A, Shiao SL, et al. Predictors of survival in head and neck mucosal melanoma. Oral Oncol. 2017;73:36\u201342.","journal-title":"Oral Oncol"},{"key":"1860_CR8","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1245\/s10434-011-1685-4","volume":"18","author":"D Jethanamest","year":"2011","unstructured":"Jethanamest D, Vila PM, Sikora AG, Morris LGT. Predictors of survival in mucosal melanoma of the head and neck. Ann Surg Oncol. 2011;18:2748\u201356.","journal-title":"Ann Surg Oncol"},{"key":"1860_CR9","doi-asserted-by":"publisher","first-page":"97","DOI":"10.21053\/ceo.2016.00094","volume":"10","author":"G Lee","year":"2017","unstructured":"Lee G, Baek C-H, Choi NY, Chung MK. The prognostic role of the surgical approach and adjuvant therapy in operable mucosal melanoma of the head and neck. Clin Exp Otorhinolaryngol. 2017;10:97\u2013103.","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"1860_CR10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/1097-0142(197408)34:2<358::AID-CNCR2820340221>3.0.CO;2-D","volume":"34","author":"M Takagi","year":"1974","unstructured":"Takagi M, Ishikawa G, Mori W. Primary malignant melanoma of the oral cavity in Japan. With special reference to mucosal melanosis. Cancer. 1974;34:358\u201370.","journal-title":"Cancer"},{"key":"1860_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S1726-4901(09)70296-5","volume":"70","author":"Y-F Cheng","year":"2007","unstructured":"Cheng Y-F, Lai C-C, Ho C-Y, Shu C-H, Lin C-Z. Toward a better understanding of sinonasal mucosal melanoma: clinical review of 23 cases. J Chin Med Assoc. 2007;70:24\u20139.","journal-title":"J Chin Med Assoc"},{"key":"1860_CR12","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0140-6736(05)66546-4","volume":"365","author":"U Veronesi","year":"2005","unstructured":"Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G. Breast cancer. Lancet (London, England). 2005;365:1727\u201341.","journal-title":"Lancet (London, England)"},{"key":"1860_CR13","first-page":"298","volume":"22","author":"Treatment of ductal carcinoma in situ","year":"2013","unstructured":"Treatment of ductal carcinoma in situ. an uncertain harm-benefit balance. Prescrire Int. 2013;22:298\u2013303.","journal-title":"Prescrire Int"},{"key":"1860_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.critrevonc.2017.01.019","volume":"112","author":"PA Ascierto","year":"2017","unstructured":"Ascierto PA, Accorona R, Botti G, Farina D, Fossati P, Gatta G, et al. Mucosal melanoma of the head and neck. Crit Rev Oncol Hematol. 2017;112:136\u201352.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1860_CR15","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1001\/jamaoncol.2020.4922","volume":"6","author":"RT Dess","year":"2020","unstructured":"Dess RT, Suresh K, Zelefsky MJ, Freedland SJ, Mahal BA, Cooperberg MR, et al. Development and validation of a clinical prognostic stage group system for nonmetastatic prostate cancer using disease-specific mortality results from the international staging collaboration for cancer of the prostate. JAMA Oncol. 2020;6:1912\u201320.","journal-title":"JAMA Oncol"},{"key":"1860_CR16","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1186\/s12885-015-1750-7","volume":"15","author":"W Li","year":"2015","unstructured":"Li W, Yu Y, Wang H, Yan A, Jiang X. Evaluation of the prognostic impact of postoperative adjuvant radiotherapy on head and neck mucosal melanoma: a meta-analysis. BMC Cancer. 2015;15:758.","journal-title":"BMC Cancer"},{"key":"1860_CR17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jcms.2015.02.011","volume":"43","author":"A Wushou","year":"2015","unstructured":"Wushou A, Hou J, Zhao Y-J, Miao X-C. Postoperative adjuvant radiotherapy improves loco-regional recurrence of head and neck mucosal melanoma. J Craniomaxillofac Surg. 2015;43:553\u20138.","journal-title":"J Craniomaxillofac Surg"},{"key":"1860_CR18","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1002\/hed.24652","volume":"39","author":"D Jarrom","year":"2017","unstructured":"Jarrom D, Paleri V, Kerawala C, Roques T, Bhide S, Newman L, et al. Mucosal melanoma of the upper airways tract mucosal melanoma: a systematic review with meta-analyses of treatment. Head Neck. 2017;39:819\u201325.","journal-title":"Head Neck"},{"key":"1860_CR19","doi-asserted-by":"publisher","first-page":"6985","DOI":"10.2147\/CMAR.S185017","volume":"10","author":"J-J Yao","year":"2018","unstructured":"Yao J-J, Zhang F, Zhang G-S, Deng X-W, Zhang W-J, Lawrence WR, et al. Efficacy and safety of primary surgery with postoperative radiotherapy in head and neck mucosal melanoma: a single-arm Phase II study. Cancer Manag Res. 2018;10:6985\u201396.","journal-title":"Cancer Manag Res"},{"key":"1860_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.21037\/atm-20-6021","volume":"9","author":"E Chen","year":"2021","unstructured":"Chen E, Wu J, Liu Z, Yang S, Wu J, Ouyang P, et al. Prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis. Ann Transl Med. 2021;9:391.","journal-title":"Ann Transl Med"},{"key":"1860_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s12105-017-0789-y","volume":"11","author":"MD Williams","year":"2017","unstructured":"Williams MD. Update from the 4th edition of the world health organization classification of head and neck tumours: mucosal melanomas. Head Neck Pathol. 2017;11:110\u20137.","journal-title":"Head Neck Pathol"},{"key":"1860_CR22","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hed.23079","volume":"35","author":"M Turri-Zanoni","year":"2013","unstructured":"Turri-Zanoni M, Medicina D, Lombardi D, Ungari M, Balzarini P, Rossini C, et al. Sinonasal mucosal melanoma: molecular profile and therapeutic implications from a series of 32 cases. Head Neck. 2013;35:1066\u201377.","journal-title":"Head Neck"},{"key":"1860_CR23","doi-asserted-by":"publisher","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","volume":"14","author":"C Beadling","year":"2008","unstructured":"Beadling C, Jacobson-Dunlop E, Hodi FS, Le C, Warrick A, Patterson J, et al. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res. 2008;14:6821\u20138.","journal-title":"Clin Cancer Res"},{"key":"1860_CR24","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/lary.25996","volume":"126","author":"DM Beswick","year":"2016","unstructured":"Beswick DM, Holsinger FC, Kaplan MJ, Fischbein NJ, Hara W, Colevas AD, et al. Design and rationale of a prospective, multi-institutional registry for patients with sinonasal malignancy. Laryngoscope. 2016;126:1977\u201380.","journal-title":"Laryngoscope"},{"key":"1860_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1200\/JCO.2016.67.9258","volume":"35","author":"SP D'Angelo","year":"2017","unstructured":"D\u2019Angelo SP, Larkin J, Sosman JA, Lebb\u00e9 C, Brady B, Neyns B, et al. Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis. J Clin Oncol. 2017;35:226\u201335.","journal-title":"J Clin Oncol"},{"key":"1860_CR26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, Green M, Choi JE, Gij\u00f3n M, Kennedy PD, Johnson JK, et al. CD8 T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569:270\u20134.","journal-title":"Nature"},{"key":"1860_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.anl.2004.03.001","volume":"31","author":"M Nakaya","year":"2004","unstructured":"Nakaya M, Mochiki M, Takeuchi S, Yuge T, Nakao K, Nakamura N, et al. Malignant melanoma of nasal cavity: report of 16 Japanese patients. Auris Nasus Larynx. 2004;31:233\u20137.","journal-title":"Auris Nasus Larynx"},{"issue":"Suppl 1","key":"1860_CR28","doi-asserted-by":"publisher","first-page":"E815","DOI":"10.1002\/hed.24106","volume":"38","author":"R Mazzola","year":"2016","unstructured":"Mazzola R, Ricchetti F, Fersino S, Fiorentino A, Giaj Levra N, Di Paola G, et al. Predictors of mucositis in oropharyngeal and oral cavity cancer in patients treated with volumetric modulated radiation treatment: A dose-volume analysis. Head Neck. 2016;38(Suppl 1):E815\u20139.","journal-title":"Head Neck"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01860-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-021-01860-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-021-01860-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T08:08:39Z","timestamp":1627459719000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-021-01860-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,28]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1860"],"URL":"https:\/\/doi.org\/10.1186\/s13014-021-01860-z","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,28]]},"assertion":[{"value":"13 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Hospital Ethics Committee at Sun Yat-sen University Cancer Center in China approved this study, which analyze anonymous data, and waived the requirement for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The Protocol Review Board and Ethics Committee of the Institute of Oncology approved the study, which was conducted in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. The need for consent was waived by the Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no actual or potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}